These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33032881)

  • 1. Corrigendum to "Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis" [Biomed. Pharmacother. 125 (2020) 110001].
    Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
    Biomed Pharmacother; 2020 Oct; 130():110841. PubMed ID: 33032881
    [No Abstract]   [Full Text] [Related]  

  • 2. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.
    Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
    Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine-mediated regulation of miR-17-3p in H9C2 cells after hypoxia/reoxygenation injury.
    Yuan T; Yang Z; Xian S; Chen Y; Wang L; Chen W; Long W; Che Y
    Exp Ther Med; 2020 Aug; 20(2):917-925. PubMed ID: 32742334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction notice to "miR-208b targets Bax to protect H9c2 cells against hypoxia-induced apoptosis" [Biomed. Pharmacother. 106 (2018) 1751-1759].
    Zhou YL; Sun Q; Zhang L; Li R
    Biomed Pharmacother; 2022 Apr; 148():112714. PubMed ID: 35164994
    [No Abstract]   [Full Text] [Related]  

  • 5. Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p.
    Bian C; Xu T; Zhu H; Pan D; Liu Y; Luo Y; Wu P; Li D
    PLoS One; 2015; 10(12):e0144877. PubMed ID: 26658785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA TALNEC2 regulates myocardial ischemic injury in H9c2 cells by regulating miR-21/PDCD4-medited activation of Wnt/β-catenin pathway.
    Hao L; Wang J; Liu N
    J Cell Biochem; 2019 Aug; 120(8):12912-12923. PubMed ID: 30861181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Concern: "Lycium barbarum polysaccharides protects H9c2 cells from hypoxia-induced injury by down-regulation of miR-122" [Biomed. Pharmacother. 110 (2019) 20-28].
    Biomed Pharmacother; 2022 Aug; 152():113047. PubMed ID: 35725098
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway" [Biomed. Pharmacother. 107 (2018) 270-282].
    Zhang B; Yu L; Han N; Hu Z; Wang S; Ding L; Jiang J
    Biomed Pharmacother; 2019 Mar; 111():1508. PubMed ID: 30600120
    [No Abstract]   [Full Text] [Related]  

  • 9. Secreted frizzled related protein 1 protects H9C2 cells from hypoxia/re-oxygenation injury by blocking the Wnt signaling pathway.
    Tao J; Abudoukelimu M; Ma YT; Yang YN; Li XM; Chen BD; Liu F; He CH; Li HY
    Lipids Health Dis; 2016 Apr; 15():72. PubMed ID: 27048460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway" [Biomed. Pharmacother. 107 (2018) 270-282].
    Zhang B; Yu L; Han N; Hu Z; Wang S; Ding L; Jiang J
    Biomed Pharmacother; 2021 Jan; 133():110893. PubMed ID: 33280928
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway" [Biomed. Pharmacother. 118 (2019) 109111].
    Wan W; Wan W; Long Y; Li Q; Jin X; Wan G; Zhang F; Lv Y; Zheng G; Li Z; Zhu Y
    Biomed Pharmacother; 2020 Nov; 131():110842. PubMed ID: 33092949
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "MiR-337-3p promotes chondrocytes proliferation and inhibits apoptosis by regulating PTEN/AKT axis in osteoarthritis" [Biomed. Pharmacother. 95 (2017) 1194-1200].
    Huang Z; Zhang N; Ma W; Dai X; Liu J
    Biomed Pharmacother; 2022 Sep; 153():113497. PubMed ID: 35948468
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of microRNA-141-3p Reduces Hypoxia-Induced Apoptosis in H9c2 Rat Cardiomyocytes by Activating the RP105-Dependent PI3K/AKT Signaling Pathway.
    Qin Q; Cui L; Zhou Z; Zhang Z; Wang Y; Zhou C
    Med Sci Monit; 2019 Sep; 25():7016-7025. PubMed ID: 31532760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-483-3p inhibition ameliorates myocardial ischemia/reperfusion injury by targeting the MDM4/p53 pathway.
    Zhang H; Wang J; Du A; Li Y
    Mol Immunol; 2020 Sep; 125():9-14. PubMed ID: 32619931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles-mediated transfer of miR-208a/b exaggerate hypoxia/reoxygenation injury in cardiomyocytes by reducing QKI expression.
    Wang F; Yuan Y; Yang P; Li X
    Mol Cell Biochem; 2017 Jul; 431(1-2):187-195. PubMed ID: 28283792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 protects against cardiac hypoxia/reoxygenation injury by inhibiting excessive autophagy in H9c2 cells via the Akt/mTOR pathway.
    Huang Z; Wu S; Kong F; Cai X; Ye B; Shan P; Huang W
    J Cell Mol Med; 2017 Mar; 21(3):467-474. PubMed ID: 27680680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferulic Acid Attenuates Hypoxia/Reoxygenation Injury by Suppressing Mitophagy Through the PINK1/Parkin Signaling Pathway in H9c2 Cells.
    Luo C; Zhang Y; Guo H; Han X; Ren J; Liu J
    Front Pharmacol; 2020; 11():103. PubMed ID: 32161543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of miR-148b ameliorates myocardial ischemia/reperfusion injury via regulation of Wnt/β-catenin signaling pathway.
    Yang M; Kong DY; Chen JC
    J Cell Physiol; 2019 Aug; 234(10):17757-17766. PubMed ID: 30820984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction notice to "TUG1 alleviates hypoxia injury by targeting miR-124 in H9c2 cells" [Biomed. Pharmacother. 103 (2018) 1669-1677].
    Jiang N; Xia J; Jiang B; Xu Y; Li Y
    Biomed Pharmacother; 2022 Jun; 150():112856. PubMed ID: 35341638
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" [Biomed. Pharmacother. 110 (2019) 656-666].
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Apr; 112():108755. PubMed ID: 30871752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.